Impact of High Disease Burden on Survival in Pediatric Patients with B-ALL Treated with Tisagenlecleucel

Ravich, JW; Huang, SJ; Zhou, YM; Brown, P; Pui, CH; Inaba, H; Cheng, C; Gottschalk, S; Triplett, BM; Bonifant, CL; Talleur, AC

Bonifant, CL (通讯作者)，Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Sch Med, 1800 Orleans St, Baltimore, MD 21287 USA.;Talleur, AC (通讯作者)，St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 262 Danny Thomas Pl, Memphis, TN 38105 USA.

TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (2):

Abstract

CD19-specific chimeric antigen receptor (CAR) T-cell therapies, including the FDA-approved tisagenlecleucel, induce high rates of remission in pediatr......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索